The Scientist - Home

An abundance of immunoglobulin antibodies, and a paucity of viral RNA, in breastmilk offer evidence that women can safely continue breastfeeding during the pandemic.

The results mark the second experimental COVID-19 vaccine to show high efficacy, but the study is not complete and the data have not been peer reviewed.

In a year of racial tumult, Black scientists are uniting for visibility and action. 

Whole genome sequencing of the virus infecting the farm animals showed that it spread from the workers to the mink and back, indicating that an animal could serve as a viral reservoir.

Their ability to distinguish between individuals is strong evidence for fast mapping, a learning tool generally thought to belong only to humans.

The state will take on additional debt to finance CIRM, which will now continue to fund stem cell research, training, and clinical trials.

A study finds that β-coronaviruses don’t use the normal secretory pathway, a possible explanation for some aspects of COVID-19 pathology.

Gamze Gursoy and Mark Gerstein of Yale Medical School have developed a strategy for stripping identifying variants from functional genomic data, balancing privacy with utility.

Mechanically sensitive proteins called gellins sense and respond to protoplasm flowing out of severed hyphae, quickly sealing up injuries in these root-like structures of fungi.

Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses. 

Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.

Jos Lelieveld of the Max Planck Institute for Chemistry explains how fine particulate might contribute to deaths from COVID-19.